We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+9.92%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$337M
AUM Growth
+$17.1M
Cap. Flow
-$9.87M
Cap. Flow %
-2.93%
Top 10 Hldgs %
39.42%
Holding
84
New
5
Increased
20
Reduced
25
Closed
4

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$4.29M
2
MRNA icon
Moderna
MRNA
+$376K
3
PG icon
Procter & Gamble
PG
+$243K
4
UNH icon
UnitedHealth
UNH
+$227K
5
IR icon
Ingersoll Rand
IR
+$224K

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$4.16M
2
EW icon
Edwards Lifesciences
EW
+$2.88M
3
NKE icon
Nike
NKE
+$2.04M
4
AMZN icon
Amazon
AMZN
+$1.69M
5
MDT icon
Medtronic
MDT
+$1.69M

Sector Composition

Rank Sector Weight
1 Technology 23.09%
2 Healthcare 22.22%
3 Industrials 14.84%
4 Consumer Discretionary 7.62%
5 Consumer Staples 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEP icon
26
PepsiCo
PEP
$185B
$4.19M 1.24%
23,215
-50
-0.2% -$8.92K
XOM icon
27
ExxonMobil
XOM
$615B
$4.01M 1.19%
36,325
+600
+2% +$64.3K
AMZN icon
28
Amazon
AMZN
$2.69T
$3.53M 1.05%
42,044
-17,127
-29% -$1.69M
PYPL icon
29
PayPal
PYPL
$50.1B
$2.63M 0.78%
36,915
-17,435
-32% -$1.4M
ILMN icon
30
Illumina
ILMN
$27.9B
$2.61M 0.77%
13,259
-2,173
-14% -$450K
NVS icon
31
Novartis
NVS
$285B
$2.58M 0.77%
28,475
-1,930
-6% -$163K
CHD icon
32
Church & Dwight Co
CHD
$23.2B
$2.49M 0.74%
30,828
-300
-1% -$23K
NKE icon
33
Nike
NKE
$64.5B
$2.38M 0.71%
20,354
-20,222
-50% -$2.04M
ABBV icon
34
AbbVie
ABBV
$448B
$1.99M 0.59%
12,337
-675
-5% -$104K
SPTM icon
35
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
$1.42M 0.42%
30,000
– –
WELL icon
36
Welltower
WELL
$173B
$1.21M 0.36%
18,500
– –
APTV icon
37
Aptiv
APTV
$12.1B
$1.11M 0.33%
11,947
-11,400
-49% -$1.08M
MDT icon
38
Medtronic
MDT
$107B
$1.08M 0.32%
13,856
-20,871
-60% -$1.69M
IRWD icon
39
Ironwood Pharmaceuticals
IRWD
$634M
$979K 0.29%
79,000
– –
MRNA icon
40
Moderna
MRNA
$23.6B
$862K 0.26%
4,800
+2,300
+92% +$376K
BMY icon
41
Bristol-Myers Squibb
BMY
$123B
$842K 0.25%
11,700
– –
BDX icon
42
Becton Dickinson
BDX
$42.6B
$765K 0.23%
3,008
+32
+1% +$7.55K
DIS icon
43
Walt Disney
DIS
$167B
$754K 0.22%
8,677
-43,503
-83% -$4.16M
PBA icon
44
Pembina Pipeline
PBA
$29.5B
$744K 0.22%
21,901
– –
MRK icon
45
Merck
MRK
$307B
$682K 0.2%
6,150
+500
+9% +$51.1K
TT icon
46
Trane Technologies
TT
$103B
$667K 0.2%
3,970
– –
EW icon
47
Edwards Lifesciences
EW
$48.9B
$619K 0.18%
8,300
-37,353
-82% -$2.88M
NVO
48
Novo Nordisk
NVO
$219B
$614K 0.18%
9,070
– –
TMO icon
49
Thermo Fisher Scientific
TMO
$196B
$592K 0.18%
1,075
– –
INTC icon
50
Intel
INTC
$488B
$523K 0.16%
19,790
-950
-5% -$26.4K
1
2
3

Similar funds

MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
GPWA
Great Point Wealth Advisors Boston, Massachusetts $542M AUM
WCA
Westover Capital Advisors Wilmington, Delaware $543M AUM 36.85% 1-Year Est. Return
ISB
Iowa State Bank Urbandale, Iowa $543M AUM 21.44% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
HCM
Hutchinson Capital Management San Rafael, California $544M AUM 9.54% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $544M AUM 18.82% 1-Year Est. Return

Brian C. Broderick's Q4 2022 Portfolio in Review

As of Q4 2022, Brian C. Broderick held 84 positions worth $337M, up 5.4% from $320M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Brian C. Broderick's Q4 2022 filing shows 5 new, 20 increased, 25 reduced and 4 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 11,162 shares worth $4.27M. The largest sale was Walt Disney, an estimated $4.16M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Brian C. Broderick's largest Q4 2022 buy was State Street SPDR S&P 500 ETF Trust: 11,162 shares worth $4.27M.
  • Brian C. Broderick added most to Moderna in Q4 2022, an estimated $376K increase.
  • Brian C. Broderick's biggest Q4 2022 reduction was Walt Disney, cutting an estimated $4.16M.
  • Brian C. Broderick fully exited Atlassian in Q4 2022, selling an estimated $316K.
  • Brian C. Broderick's ten largest holdings make up 39% of its $337M portfolio in Q4 2022.
  • Brian C. Broderick opened 5 new positions and closed 4 in Q4 2022.
  • Brian C. Broderick's portfolio value rose 5.4% quarter-over-quarter to $337M.

Based on Brian C. Broderick's 13F filing for Q4 2022, filed 9 Feb 2023.